(1R,2S)-2-(3-bromophenyl)cyclopropanamine hydrochloride CAS:1314324-03-2

The primary utilization of (1R,2S)-2-(3-bromophenyl)cyclopropanamine hydrochloride is in medicinal chemistry and drug discovery. Its distinctive structure enables researchers to explore its role as a precursor in creating new compounds with specific biological activities. This compound is commonly employed in the development of pharmaceuticals targeting diverse therapeutic areas, including neuroscience, psychiatry, and pain management. In drug development, (1R,2S)-2-(3-bromophenyl)cyclopropanamine hydrochloride serves as a critical intermediate in the synthesis of potential drug candidates. Its stereochemical configuration and functional groups can influence the biological properties and interactions of resultant compounds, impacting their efficacy and selectivity. Researchers leverage the unique features of this compound to modulate the pharmacological characteristics of new drug molecules, leading to optimized treatments for various medical conditions. Moreover, (1R,2S)-2-(3-bromophenyl)cyclopropanamine hydrochloride finds application in preclinical studies to assess the pharmacological profiles and toxicity levels of emerging drug compounds. Its role in these studies involves evaluating the metabolic stability, receptor binding affinity, and therapeutic potential of experimental drugs. By incorporating this compound into drug design and testing processes, researchers gain insights crucial for advancing promising pharmaceutical agents towards clinical trials. Overall, (1R,2S)-2-(3-bromophenyl)cyclopropanamine hydrochloride contributes significantly to pharmaceutical research by facilitating the development of innovative drugs with tailored pharmacological properties, paving the way for improved therapeutic interventions across various disease indications.